According to a recent LinkedIn post from PictorLabs, the company is highlighting a joint session with Proscia at the USCAP 2026 conference focused on integrating virtual staining into existing digital pathology workflows. The post indicates the session will demonstrate capabilities such as single-section pathology, multi-marker stains generated on demand, and seamless integration with image management systems, including on-premise deployment options.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes that attendees can see a live scan-to-virtual-stain demonstration at PictorLabs’ booth, using a Grundium Ocus 40 scanner to produce virtual stains in real time. For investors, this emphasis on interoperability with incumbent slide scanners and digital platforms suggests a strategy aimed at lowering adoption barriers and positioning virtual staining as a workflow upgrade rather than a wholesale infrastructure replacement.
If these integrations gain traction, PictorLabs could tap into existing installed bases of scanners and digital pathology systems, potentially accelerating commercial uptake and recurring software revenue. The collaboration with Proscia and visibility at a major pathology conference may also enhance the company’s standing among pathology labs and health systems, supporting its competitive position in AI-driven digital pathology.